198 related articles for article (PubMed ID: 15797738)
21. Excellent renal allograft survival in donor-specific antibody positive transplant patients-role of intravenous immunoglobulin and rabbit antithymocyte globulin.
Mai ML; Ahsan N; Wadei HM; Genco PV; Geiger XJ; Willingham DL; Taner CB; Hewitt WR; Grewal HP; Nguyen JH; Hughes CB; Gonwa TA
Transplantation; 2009 Jan; 87(2):227-32. PubMed ID: 19155977
[TBL] [Abstract][Full Text] [Related]
22. The duration of administration of monoclonal antibody OKT3 for induction immunosuppression after heart transplantation.
Aleksic I; Freimark D; Blanche C; Czer LS; Dalichau H; Valenza M; Takkenberg JJ; Trento A
Thorac Cardiovasc Surg; 1997 Aug; 45(4):190-5. PubMed ID: 9323821
[TBL] [Abstract][Full Text] [Related]
23. Risk/benefit ratio of perioperative OKT3 in cardiac transplantation.
Johnson MR; Mullen GM; O'Sullivan EJ; Liao Y; Heroux AL; Kao W; Pifarre R; Costanzo-Nordin MR
Transplant Proc; 1993 Feb; 25(1 Pt 2):1149-51. PubMed ID: 8442068
[TBL] [Abstract][Full Text] [Related]
24. Rejection after cardiac transplantation. A time-related risk factor analysis.
Kirklin JK; Naftel DC; Bourge RC; White-Williams C; Caulfield JB; Tarkka MR; Holman WL; Zorn GL
Circulation; 1992 Nov; 86(5 Suppl):II236-41. PubMed ID: 1424006
[TBL] [Abstract][Full Text] [Related]
25. Ten-year follow-up of a prospective, randomized trial of BT563/bb10 versus anti-thymocyte globulin as induction therapy after heart transplantation.
Bonaros N; Dunkler D; Kocher A; Imhof M; Grimm M; Zuckermann A; Wolner E; Laufer G
J Heart Lung Transplant; 2006 Sep; 25(9):1154-63. PubMed ID: 16962480
[TBL] [Abstract][Full Text] [Related]
26. Strategies of immunosuppression in cardiac transplantation.
Renlund DG; O'Connell JB; Bristow MR
Semin Thorac Cardiovasc Surg; 1990 Apr; 2(2):181-8. PubMed ID: 2127901
[TBL] [Abstract][Full Text] [Related]
27. Selective use of OKT3 in heart transplantation with the use of risk factor analysis.
Macris MP; Van Buren CT; Sweeney MS; Frazier OH; Duncan JM
J Heart Transplant; 1989; 8(4):296-302. PubMed ID: 2504896
[TBL] [Abstract][Full Text] [Related]
28. Risk factors and consequences of delayed graft function in deceased donor renal transplant patients receiving antithymocyte globulin induction.
Patel SJ; Duhart BT; Krauss AG; Moore LW; Egidi MF; Amiri HS; Gaber LW; Gaber AO
Transplantation; 2008 Jul; 86(2):313-20. PubMed ID: 18645496
[TBL] [Abstract][Full Text] [Related]
29. Outcome of heart transplants 15 to 20 years ago: graft survival, post-transplant morbidity, and risk factors for mortality.
Roussel JC; Baron O; Périgaud C; Bizouarn P; Pattier S; Habash O; Mugniot A; Petit T; Michaud JL; Heymann MF; Treilhaud M; Trochu JN; Gueffet JP; Lamirault G; Duveau D; Despins P
J Heart Lung Transplant; 2008 May; 27(5):486-93. PubMed ID: 18442713
[TBL] [Abstract][Full Text] [Related]
30. Lung transplantation: a decade of experience.
Moffatt SD; Demers P; Robbins RC; Doyle R; Wienacker A; Henig N; Theodore J; Reitz BA; Whyte RI
J Heart Lung Transplant; 2005 Feb; 24(2):145-51. PubMed ID: 15701428
[TBL] [Abstract][Full Text] [Related]
31. Monoclonal versus polyclonal antibody therapy for prophylaxis against rejection after heart transplantation.
Kormos RL; Herlan DB; Armitage JM; Stein K; Kaufman C; Zeevi A; Duquesnoy R; Hardesty RL; Griffith BP
J Heart Transplant; 1990; 9(1):1-9, discussion 9-10. PubMed ID: 2107288
[TBL] [Abstract][Full Text] [Related]
32. Effects of induction immunosuppression regimen on acute rejection, bronchiolitis obliterans, and survival after lung transplantation.
Ailawadi G; Smith PW; Oka T; Wang H; Kozower BD; Daniel TM; Kron IL; Jones DR
J Thorac Cardiovasc Surg; 2008 Mar; 135(3):594-602. PubMed ID: 18329476
[TBL] [Abstract][Full Text] [Related]
33. Outcomes in patients older than 60 years of age undergoing orthotopic heart transplantation: an analysis of the UNOS database.
Weiss ES; Nwakanma LU; Patel ND; Yuh DD
J Heart Lung Transplant; 2008 Feb; 27(2):184-91. PubMed ID: 18267225
[TBL] [Abstract][Full Text] [Related]
34. Single-shot antithymocyte globulin (ATG) induction for pancreas/kidney transplantation: ATG-Fresenius versus Thymoglobulin.
Schulz T; Papapostolou G; Schenker P; Kapischke M
Transplant Proc; 2005 Mar; 37(2):1301-4. PubMed ID: 15848703
[TBL] [Abstract][Full Text] [Related]
35. Early screening for antibody-mediated rejection in heart transplant recipients.
Kfoury AG; Hammond ME; Snow GL; Stehlik J; Reid BB; Long JW; Gilbert EM; Bader FM; Bull DA; Renlund DG
J Heart Lung Transplant; 2007 Dec; 26(12):1264-9. PubMed ID: 18096477
[TBL] [Abstract][Full Text] [Related]
36. OKT3 induction therapy: influence of duration on rejections and infections.
Zibari GB; Boykin KN; Thomas JP; Aultman DF; Aradhye SA; McMillan RW; McDonald JC
Clin Transplant; 1996 Dec; 10(6 Pt 2):614-6. PubMed ID: 8996752
[TBL] [Abstract][Full Text] [Related]
37. Daclizumab is associated with decreased rejection and improved patient survival in renal transplant recipients.
Morris JA; Hanson JE; Steffen BJ; Chu AH; Chi-Burris KS; Gotz VP; Gordon RD
Clin Transplant; 2005 Jun; 19(3):340-5. PubMed ID: 15877795
[TBL] [Abstract][Full Text] [Related]
38. HLA-specific antibodies are associated with high-grade and persistent-recurrent lung allograft acute rejection.
Girnita AL; McCurry KR; Iacono AT; Duquesnoy R; Corcoran TE; Awad M; Spichty KJ; Yousem SA; Burckart G; Dauber JH; Griffith BP; Zeevi A
J Heart Lung Transplant; 2004 Oct; 23(10):1135-41. PubMed ID: 15477106
[TBL] [Abstract][Full Text] [Related]
39. The influence of HLA mismatches and immunosuppression on kidney graft survival: an analysis of more than 1300 patients.
Martins L; Fonseca I; Sousa S; Matos C; Santos J; Dias L; Henriques AC; Sarmento AM; Cabrita A
Transplant Proc; 2007 Oct; 39(8):2489-93. PubMed ID: 17954156
[TBL] [Abstract][Full Text] [Related]
40. Renal transplantation at the Washington Hospital Center: experience with OKT3 and Minnesota antilymphoblast globulin for induction of immunosuppression.
Jonsson J; Light JA; Korb SM
Clin Transpl; 1990; ():275-88. PubMed ID: 2129409
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
